UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Pathological roles of α-synuclein in neurological disorders

Lancet neurology, 2011-11, Vol.10 (11), p.1015-1025

2011

Link zum Volltext

Verfügbarkeit prüfen

The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease

Neurochemical research, 2014-03, Vol.39 (3), p.576-592

2014

Link zum Volltext

Verfügbarkeit prüfen

Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs homo-dimeric complexes

Biochemical journal, 2019-02, Vol.476 (3), p.559-579

2019

Link zum Volltext

Verfügbarkeit prüfen

LRRK2 Parkinson disease mutations enhance its microtubule association

Human molecular genetics, 2012-02, Vol.21 (4), p.890-899

2012

Link zum Volltext

Verfügbarkeit prüfen

Defining (and blocking) neuronal death in Parkinson’s disease: Does it matter what we call it?

Brain research, 2021-11, Vol.1771, p.147639-147639, Article 147639

2021

Link zum Volltext

Verfügbarkeit prüfen

Nurr1: RXRα heterodimer activation as monotherapy for Parkinson’s disease

Proceedings of the National Academy of Sciences - PNAS, 2017-04, Vol.114 (15), p.3999-4004

2017

Link zum Volltext

Verfügbarkeit prüfen

Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk

Journal of Parkinson's disease, 2023-01, Vol.13 (7), p.1077-1078

2023

Link zum Volltext

Verfügbarkeit prüfen

P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity

Biochemical journal, 2018-04, Vol.475 (7), p.1271-1293

2018

Link zum Volltext

Verfügbarkeit prüfen

The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration

The Journal of neuroscience, 2009-01, Vol.29 (4), p.1011-1016

2009

Link zum Volltext

Verfügbarkeit prüfen

Leucine-Rich Repeat Kinase 2 (LRRK2)

1, 2017

Link zum Volltext

Verfügbarkeit prüfen

Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based Method

Movement disorders, 2020-11, Vol.35 (11), p.2095-2100

2020

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal transcriptomic analysis of mouse sciatic nerve reveals pathways associated with age‐related muscle pathology

Journal of cachexia, sarcopenia and muscle, 2023-06, Vol.14 (3), p.1322-1336

2023

Link zum Volltext

Verfügbarkeit prüfen

Involvement of macroautophagy in the dissolution of neuronal inclusions

The international journal of biochemistry & cell biology, 2004-12, Vol.36 (12), p.2551-2562

2004

Link zum Volltext

Verfügbarkeit prüfen

Expression of A53T Mutant But Not Wild-Type alpha -Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death

The Journal of neuroscience, 2001-12, Vol.21 (24), p.9549-9560

2001

Link zum Volltext

Verfügbarkeit prüfen

Proteasomal inhibition leads to formation of ubiquitin/α‐synuclein‐immunoreactive inclusions in PC12 cells

Journal of neurochemistry, 2001-08, Vol.78 (4), p.899-908

2001

Link zum Volltext

Verfügbarkeit prüfen

Leucine rich repeat kinase 2 (LRRK2) peptide modulators: Recent advances and future directions

Peptide science (Hoboken, N.J.), 2022-01, Vol.114 (1), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Proteasomal Inhibition-Induced Inclusion Formation and Death in Cortical Neurons Require Transcription and Ubiquitination

Molecular and cellular neuroscience, 2002-10, Vol.21 (2), p.223-238

2002

Link zum Volltext

Verfügbarkeit prüfen

Proteasome inhibition and Parkinson's disease modeling

Annals of neurology, 2006-08, Vol.60 (2), p.260-264

2006

Link zum Volltext

Verfügbarkeit prüfen

Neurobiology of alpha-synuclein

Molecular neurobiology, 2004-08, Vol.30 (1), p.1-22

2004

Link zum Volltext

Verfügbarkeit prüfen

Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up‐regulate iHSP70, following proteasomal inhibition

Journal of neurochemistry, 2005-06, Vol.93 (5), p.1304-1313

2005

Link zum Volltext

Verfügbarkeit prüfen

Cyclin-Dependent Kinase Activity Is Required for Apoptotic Death But Not Inclusion Formation in Cortical Neurons after Proteasomal Inhibition

The Journal of neuroscience, 2003-02, Vol.23 (4), p.1237-1245

2003

Link zum Volltext

Verfügbarkeit prüfen

Targeted disruption of neuronal 19S proteasome subunits induces the formation of ubiquitinated inclusions in the absence of cell death

Journal of neurochemistry, 2011-11, Vol.119 (3), p.630-643

2011

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Caspase-Independent Neuronal Death: Energy Depletion and Free Radical Generation

The Journal of neuroscience, 2003-12, Vol.23 (35), p.11015-11025

2003

Link zum Volltext

Verfügbarkeit prüfen

Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway

Journal of neurochemistry, 2004-09, Vol.90 (6), p.1511-1520

2004

Link zum Volltext

Verfügbarkeit prüfen

alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons

The Journal of biological chemistry, 2004-11, Vol.279 (45), p.46915-46920

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

ThemaMutation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(48)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pathological roles of α-synuclein in neurological disorders

The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease

Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs homo-dimeric complexes

LRRK2 Parkinson disease mutations enhance its microtubule association

Defining (and blocking) neuronal death in Parkinson’s disease: Does it matter what we call it?

Nurr1: RXRα heterodimer activation as monotherapy for Parkinson’s disease

Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk

P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity

The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration

Leucine-Rich Repeat Kinase 2 (LRRK2)

Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based Method

Longitudinal transcriptomic analysis of mouse sciatic nerve reveals pathways associated with age‐related muscle pathology

Involvement of macroautophagy in the dissolution of neuronal inclusions

Expression of A53T Mutant But Not Wild-Type alpha -Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death

Proteasomal inhibition leads to formation of ubiquitin/α‐synuclein‐immunoreactive inclusions in PC12 cells

Leucine rich repeat kinase 2 (LRRK2) peptide modulators: Recent advances and future directions

Proteasomal Inhibition-Induced Inclusion Formation and Death in Cortical Neurons Require Transcription and Ubiquitination

Proteasome inhibition and Parkinson's disease modeling

Neurobiology of alpha-synuclein

Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up‐regulate iHSP70, following proteasomal inhibition

Cyclin-Dependent Kinase Activity Is Required for Apoptotic Death But Not Inclusion Formation in Cortical Neurons after Proteasomal Inhibition

Targeted disruption of neuronal 19S proteasome subunits induces the formation of ubiquitinated inclusions in the absence of cell death

Mechanisms of Caspase-Independent Neuronal Death: Energy Depletion and Free Radical Generation

Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway

alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons

Aktive Filter

Suchergebnisse filtern